Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19.
Eur J Intern Med. 2021 Jan;83:34-38. doi: 10.1016/j.ejim.2020.10.020. Epub 2020 Nov 3.
Eur J Intern Med. 2021.
PMID: 33162299
Free PMC article.
Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation.
Potere N, Di Nisio M, Rizzo G, La Vella M, Polilli E, Agostinone A, Spacone A, Di Carlo S, Costantini A, Abbate A, Porreca E, Parruti G.
Potere N, et al. Among authors: la vella m.
Int J Infect Dis. 2020 Nov;100:421-424. doi: 10.1016/j.ijid.2020.07.078. Epub 2020 Aug 6.
Int J Infect Dis. 2020.
PMID: 32768701
Free PMC article.
Item in Clipboard
Cite
Cite